相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis
Giulio Disanto et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Rituximab in refractory chronic inflammatory demyelinating polyneuropathy
Suraj A. Muley et al.
MUSCLE & NERVE (2020)
Efficacy of low dose rituximab in treatment-resistant CIDP with antibodies against NF-155
Li Jiao et al.
JOURNAL OF NEUROIMMUNOLOGY (2020)
Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy
Anna Lena Fisse et al.
NEUROLOGICAL RESEARCH AND PRACTICE (2020)
Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model
Kathrin Doppler et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy
Elba Pascual-Goni et al.
SCIENTIFIC REPORTS (2019)
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database
Pietro Emiliano Doneddu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome
Andrew P. Maxted et al.
PEDIATRIC NEPHROLOGY (2019)
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial (vol 17, pg 35, 2018)
I. N. van Schaik et al.
LANCET NEUROLOGY (2018)
COMPOSITE GANGLIOSIDE AUTOANTIBODIES AND IMMUNE TREATMENT RESPONSE IN MMN AND MADSAM
Jennifer M. Martinez-Thompson et al.
MUSCLE & NERVE (2018)
Autoantibodies Against the Node of Ranvier in Seropositive Chronic inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance
Atay Vural et al.
FRONTIERS IN IMMUNOLOGY (2018)
Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy with associated diseases
Thomas Roux et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2018)
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
Ivo N. van Schaik et al.
LANCET NEUROLOGY (2018)
Complement deposition induced by binding of anti-contactin-1 auto-antibodies is modified by immunoglobulins
Luise Appeltshauser et al.
EXPERIMENTAL NEUROLOGY (2017)
Severe refractory CIDP: a case series of 10 patients treated with bortezomib
Kalliopi Pitarokoili et al.
JOURNAL OF NEUROLOGY (2017)
Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases
Daniele Velardo et al.
JOURNAL OF NEUROLOGY (2017)
Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications
Luis Querol et al.
NATURE REVIEWS NEUROLOGY (2017)
Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy
Luis Querol et al.
SCIENTIFIC REPORTS (2017)
Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy
Kathrin Doppler et al.
BRAIN (2016)
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy
Jerome J. Devaux et al.
NEUROLOGY (2016)
Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies
Kathrin Doppler et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
Luis Querol et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Epidemiology of chronic inflammatory neuropathies in southeast England
M. Mahdi-Rogers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy
Luis Querol et al.
ANNALS OF NEUROLOGY (2013)
Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG the ICE study
E. K. Vanhoutte et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis
D. Cocito et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature
L. Benedetti et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies
S. I. van Nes et al.
NEUROLOGY (2011)
Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy
Min-Suk Yoon et al.
Therapeutic Advances in Neurological Disorders (2011)
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy
D. Cocito et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision
P. Y. K. Van den Bergh et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy
Pierre Lozeron et al.
ARCHIVES OF NEUROLOGY (2009)
EPIDEMIOLOGIC VARIABILITY OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY WITH DIFFERENT DIAGNOSTIC CRITERIA: STUDY OF A UK POPULATION
Yusuf A. Rajabally et al.
MUSCLE & NERVE (2009)
Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With Pulsed Oral Steroids
Suraj Ashok Muley et al.
ARCHIVES OF NEUROLOGY (2008)
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
Richard A. C. Hughes et al.
LANCET NEUROLOGY (2008)
Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone
G Lopate et al.
ARCHIVES OF NEUROLOGY (2005)
Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies
ISJ Merkies et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
分享论文
